U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H16O5
Molecular Weight 324.3273
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 6-HYDROXYWARFARIN

SMILES

CC(=O)CC(C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC(O)=C3

InChI

InChIKey=IQWPEJBUOJQPDE-UHFFFAOYSA-N
InChI=1S/C19H16O5/c1-11(20)9-14(12-5-3-2-4-6-12)17-18(22)15-10-13(21)7-8-16(15)24-19(17)23/h2-8,10,14,21-22H,9H2,1H3

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.
2009 Jul
Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.
2010 May 17
Patents
Name Type Language
6-HYDROXYWARFARIN
Common Name English
6-HYDROXYWARFARIN, (RS)-
Common Name English
6-HYDROXYWARFARIN, (±)-
Common Name English
2H-1-BENZOPYRAN-2-ONE, 4,6-DIHYDROXY-3-(3-OXO-1-PHENYLBUTYL)-
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID50939073
Created by admin on Sat Dec 16 08:47:08 GMT 2023 , Edited by admin on Sat Dec 16 08:47:08 GMT 2023
PRIMARY
CAS
17834-02-5
Created by admin on Sat Dec 16 08:47:08 GMT 2023 , Edited by admin on Sat Dec 16 08:47:08 GMT 2023
PRIMARY
PUBCHEM
54682459
Created by admin on Sat Dec 16 08:47:08 GMT 2023 , Edited by admin on Sat Dec 16 08:47:08 GMT 2023
PRIMARY
FDA UNII
P25D26M0HK
Created by admin on Sat Dec 16 08:47:08 GMT 2023 , Edited by admin on Sat Dec 16 08:47:08 GMT 2023
PRIMARY